VMD Stock Analysis: Buy, Sell, or Hold?
VMD - Viemed Healthcare, Inc. Common Shares
$8.79
0.04 (0.46%)
â˛
5d:
-2.44%
30d:
-5.08%
90d:
-15.64%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When VMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: VMD is fairly priced but lacks strong directional signals. At 1.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: VMD is fairly priced but lacks strong directional signals. At 1.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.19
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.05
12.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VMD is currently trading at $8.79, which is considered slightly low relative to its 30-day fair value range of $8.78 to $9.42. The stock's valuation (Forward PE: 16.2) is in line with its historical norms (15.3). At these levels, the market is pricing in 1.9% annual earnings growth.
Technical Outlook: Technically, VMD is showing sideways momentum. The price is currently testing key support at $8.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VMD scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.50 (+42.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VMD is showing sideways momentum. The price is currently testing key support at $8.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VMD scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.50 (+42.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$8.78 -
$9.42
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.2% below Wall St target ($12.50)
- BULLISH: Expecting earnings turnaround to 1.9% growth with 23.9% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.78 -
$9.42
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
Âą$0.73
(8.3%)
Support & Resistance Levels
Support Level
$8.60
Resistance Level
$9.23
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.18
Wall Street Target
$12.50
(+42.2%)
Revenue Growth (YoY)
23.9%
Earnings Growth (YoY)
-12.4%
Profit Margin
4.8%
Valuation Premium vs History
+1.9% premium
PE vs Historical
16.2 vs 15.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.9%
(market-implied from PE analysis)
1-Year Target
$8.96
(+2%)
2-Year Target
$9.13
(+4%)
3-Year Target
$9.30
(+6%)
3-Yr Target (if PE normalizes)
(PE: 16â15)
PE COMPRESSION
$8.80
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 31.5%)
$24.89
(+183%)
Base:
(SPY PE: 16.2, Growth: 31.5%)
$19.97
(+127%)
Bear:
(PE: 13.8, Growth: 31.5%)
$16.97
(+93%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 24.31 | Current EPS (TTM): $0.36
Bull Case
$14.53
(+65%)
Analyst growth 50.9%, PE expands to 26.7
Base Case
$13.21
(+50%)
Market implied 50.9%, PE stable at 24.3
Bear Case
$5.95
(-32%)
Severe decline -20.0%, PE contracts to 20.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 9:37 AM ET
Data refreshes hourly during market hours. Next update: 10:37 AM
Data refreshes hourly during market hours. Next update: 10:37 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Moore
SELL
65000 shares
2026-03-20
Michael Moore
SELL
40232 shares
2026-03-19
Michael Moore
SELL
31570 shares
2026-03-18
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
ZBH
Zimmer Biomet Holdings IâĻ |
HOLD
29 analysts |
$108 | 50 HOLD |
